✦ LIBER ✦

461 PUBLICATION Long-term safety of intravenous ibandronate throughout 4 years of treatment for metastatic breast cancer

Book ID: 118623040
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 142 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)80758-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

444 PUBLICATION Long-term safety of oral

444 PUBLICATION Long-term safety of oral ibandronate for metastatic breast cancer: 4-year treatment data

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Long-Term Safety of Intravenous Ibandron

Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer

✍ Dr Martin Pecherstorfer, Saul Rivkin, Jean-Jacques Body, Ingo Diel, Bengt Bergst 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 110 KB

Long-term (4-year) safety of intravenous

Long-term (4-year) safety of intravenous Ibandronate in metastatic breast cancer: an open-label study

✍ M Pecherstorfer; I.J Diel; B Bergstrom 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Long-term safety of oral ibandronate in

Long-term safety of oral ibandronate in patients with skeletal metastases from breast cancer: 4-year follow-up data

✍ D Cameron; R Murray; D Tripathy; B Bergström 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB